Evidence map›Paper›PMID 35893036›Full record

ArticleGenes2022

Differential Methylation Profile in Fragile X Syndrome-Prone Offspring Mice after in Utero Exposure to Lactobacillus Reuteri.

Reem R AlOlaby, Marwa Zafarullah, Mariana Barboza, Gang Peng, Bernard J Varian, Susan E Erdman, Carlito Lebrilla, Flora Tassone

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Genes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06279858 (Probiotic Intervention for Microbiome Modifications and Consequential Clinical Improvements in Children With Fragile X Syndrome), which is not on this map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06279858 naunknown statusnot on this mapstarted 2024, after this paper: background citation

Probiotic Intervention for Microbiome Modifications and Consequential Clinical Improvements in Children With Fragile X Syndrome: Pilot Study

TypeinterventionalSponsorSpecila hospital for cerebral palsy and developmental neurologyRan2024 to 2024Enrolled15ConditionsFragile X SyndromeArmsProbiotics
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. The gut microbiome and sociability.Frontiers in neuroscience · 2024
    Review
  8. Oxytocin and the microbiome.Comprehensive psychoneuroendocrinology · 2023
    Review
  9. Review
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Reem R AlOlabyDepartment of Mathematics & Sciences, College of Health Sciences, California Northstate University, Sacramento, CA 95670, USA.
Marwa ZafarullahBiochemistry and Molecular Medicine, University of California, Davis, Sacramento, CA 95817, USA.ORCID 0000-0003-1856-0535
Mariana BarbozaBiochemistry and Molecular Medicine, University of California, Davis, Sacramento, CA 95817, USA.
Gang PengDepartment of Biostatistics, Yale University School of Public Health, New Haven, CT 06510, USA.ORCID 0000-0003-0307-9351
Bernard J VarianDivision of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.ORCID 0000-0002-1456-4873
Susan E ErdmanDivision of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.ORCID 0000-0002-0916-6811
Carlito LebrillaBiochemistry and Molecular Medicine, University of California, Davis, Sacramento, CA 95817, USA.
Flora TassoneBiochemistry and Molecular Medicine, University of California, Davis, Sacramento, CA 95817, USA.ORCID 0000-0002-6388-9180
University of California, Davis · USMassachusetts Institute of Technology · USCalifornia Northstate University · USYale University · US

Funding

LINGUISTIC COMMUNICATION AND MENTAL RETARDATIONR01HD024356 · NICHD · UNIVERSITY OF WISCONSIN-MADISON · PI ABBEDUTO, LEONARD J. · 1987 to 2022
$9.0M
GI Tract Dysbiosis and Breast CancerU01CA164337 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI ERDMAN, SUSAN E, WANG, TIMOTHY CRAGIN · 2012 to 2016
$2.6M
NCI NIH HHS U01 CA164337NICHD NIH HHS R01 HD024356
6 · The paper itself

Abstract

Environmental factors such as diet, gut microbiota, and infections have proven to have a significant role in epigenetic modifications. It is known that epigenetic modifications may cause behavioral and neuronal changes observed in neurodevelopmental disabilities, including fragile X syndrome (FXS) and autism (ASD). Probiotics are live microorganisms that provide health benefits when consumed, and in some cases are shown to decrease the chance of developing neurological disorders. Here, we examined the epigenetic outcomes in offspring mice after feeding of a probiotic organism,

Indexed as

Fragile X SyndromeLimosilactobacillus reuteriProbioticsAnimalsFragile X Messenger Ribonucleoprotein 1MethylationMiceFragile X Messenger Ribonucleoprotein 1ASDepigeneticsFXSin uteroLactobacillus reuterimethylation

Identifiers

PMID35893036
PMCPMC9331364
OpenAlexW4286587730

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.